Skip to content
  • +49 6173 3941016
  • ws@value-dossier.com
Value Dossier Icon
  • Services
    • AMNOG Negotiation Guide
    • German Benefit Assessment (AMNOG)
    • Strategic Market Access Consulting
    • AMNOG price negotiations
    • Reference pricing for pharmaceuticals
    • European Health Technology Assessment (EU-HTA)
    • European Reference Price Calculator
    • Reimbursement of Medical Devices
    • HTA Services
  • About us
    • Team
    • Publications
    • Partner
    • Corporate mission
  • News
  • Contact
  • Deutsch
Next

Scientific article: Additional benefits of matrix-associated autologous chondrocyte implantation

  • DNA DNS Doppelhelix© Dan Race -stock.adobe.com #134867088
Admin2022-04-05T15:02:47+02:0022. July 2021|AMNOG Benefit Assessment, HTA Services, Market Access Consulting|0 Comments

Beitrag teilen ...

FacebookTwitterLinkedInWhatsAppXingEmail

Categories

WS Value & Dossier GmbH
Your specialists for market access and reimbursement.

Rheinstr. 2
65760 Eschborn
Germany

phone: +49 6173 3941016
fax: +49 6173 39411021

Value Dossier Icon

Legal

Privacy Policy
Imprint

© Copyright 2025 | WS Value Dossier GmbH

Page load link
Go to Top